Hyperphosphataemia

DBCOND0015896Nutritional and Metabolic Diseases

Hyperphosphataemia is the indication for 10 drugs in DrugBank. It is covered by 10 curated, structured indications.

Also known as
Hyperphosphatemia
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0506086SNOMED CT20165001MedDRA10020711UMLSC0085681

What you can answer from here — as of October 22, 2026

10Indicated drugsWith each drug's targets and mechanism
Listed above
10Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
134Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
29Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Hyperphosphataemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In